Bioventus (BVS) News Today $9.49 -1.45 (-13.25%) Closing price 04:00 PM EasternExtended Trading$9.66 +0.17 (+1.79%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Consumer Sentiment Just Crashed Below the Recession Threshold. These 3 Defensive Stocks Under $25 Are Built for What Comes NextMay 14, 2026 | 247wallst.comBioventus (BVS) Q1 2026 Earnings TranscriptMay 7, 2026 | finance.yahoo.comBioventus Inc. (BVS) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comBioventus Inc. 2026 Q1 - Results - Earnings Call PresentationMay 6, 2026 | seekingalpha.comBioventus (NASDAQ:BVS) Reaches New 1-Year High on Better-Than-Expected EarningsMay 6, 2026 | marketbeat.comBioventus Q1 Earnings Call HighlightsMay 6, 2026 | marketbeat.comBioventus (NASDAQ:BVS) Updates FY 2026 Earnings GuidanceMay 6, 2026 | marketbeat.comBioventus Reports First Quarter Financial ResultsMay 6, 2026 | globenewswire.comBioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by BrokeragesMay 1, 2026 | marketbeat.comBioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026April 28, 2026 | globenewswire.comBioventus Inc. ($BVS) CEO 2025 Pay RevealedApril 22, 2026 | quiverquant.comQBioventus, Inc. Class AApril 16, 2026 | edition.cnn.comMichelle Mcmurry-Heath Sells 12,000 Shares of Bioventus (NASDAQ:BVS) StockMarch 14, 2026 | insidertrades.comBioventus Inc. (NASDAQ:BVS) Q4 2025 earnings call transcriptMarch 6, 2026 | msn.comBioventus shares jump 7.6% on fourth-quarter earnings beatMarch 5, 2026 | za.investing.comBioventus outlines $600M–$610M 2026 sales target with accelerated investment in PNS, PRP, and ultrasonicsMarch 5, 2026 | seekingalpha.comBioventus (BVS) Q4 2025 Earnings Call TranscriptMarch 5, 2026 | finance.yahoo.comBioventus Inc (BVS) Q4 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...March 5, 2026 | finance.yahoo.comBioventus Inc. 2025 Q4 - Results - Earnings Call PresentationMarch 5, 2026 | seekingalpha.comBioventus Announces Fourth Quarter and Full Year 2025 Financial ResultsMarch 5, 2026 | globenewswire.comBioventus Inc. to Report Fourth Quarter Fiscal Year 2025 Financial Results on March 5, 2026February 24, 2026 | quiverquant.comQBioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026February 24, 2026 | globenewswire.comAnalysts Conflicted on These Healthcare Names: Healthcare Services (HCSG) and Bioventus (BVS)February 13, 2026 | theglobeandmail.comThose who invested in Bioventus (NASDAQ:BVS) three years ago are up 413%February 10, 2026 | finance.yahoo.comBarrington Research initiates coverage of Bioventus (BVS) with outperform recommendationFebruary 10, 2026 | msn.comBioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 15, 2026 | seekingalpha.comBioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14, 2026 | seekingalpha.comInstitutional investors own a significant stake of 36% in Bioventus Inc. (NASDAQ:BVS)January 14, 2026 | finance.yahoo.comBioventus to Present at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2026 | globenewswire.comBioventus (NYSE:BVS) Director Guy Nohra Sells 10,000 Shares of StockDecember 9, 2025 | insidertrades.comHALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSDecember 5, 2025 | prnewswire.comBioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare Conference - SlideshowDecember 4, 2025 | seekingalpha.comIs It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)?December 4, 2025 | finance.yahoo.comBioventus: A New StartDecember 2, 2025 | seekingalpha.comBioventus to Present at the Piper Sandler 37th Annual Healthcare ConferenceNovember 25, 2025 | globenewswire.comBioventus Appoints Ajay Dhankhar as New DirectorNovember 17, 2025 | tipranks.comDirector Of Bioventus Sold $131K In StockNovember 11, 2025 | benzinga.comBioventus Inc. 2025 Q3 - Results - Earnings Call PresentationNovember 7, 2025 | seekingalpha.comBioventus Inc. Just Recorded A 36% EPS Beat: Here's What Analysts Are Forecasting NextNovember 7, 2025 | finance.yahoo.comBioventus Inc. (NASDAQ:BVS) Q3 2025 Earnings Call TranscriptNovember 5, 2025 | insidermonkey.comBioventus (BVS): One-Off $17.3M Loss Challenges Bullish Narratives After Profitability MilestoneNovember 5, 2025 | uk.finance.yahoo.comBioventus, Inc. Reports Strong Q3 Earnings GrowthNovember 5, 2025 | msn.comBioventus Inc (BVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ChallengesNovember 4, 2025 | uk.finance.yahoo.comBioventus Inc. (BVS) Q3 2025 Earnings Call TranscriptNovember 4, 2025 | seekingalpha.comBioventus tops Q3 expectations as organic revenue grows 8%November 4, 2025 | investing.comBioventus Inc. Reports Q3 2025 Results: $138.7 Million in Revenue, Profitability Gains, and Continued Guidance ReaffirmationNovember 4, 2025 | quiverquant.comQBioventus Reports Third Quarter Financial ResultsNovember 4, 2025 | globenewswire.comWhat To Expect From Bioventus Inc (BVS) Q3 2025 EarningsNovember 3, 2025 | finance.yahoo.comBioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025October 28, 2025 | globenewswire.comHalper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their RightsOctober 22, 2025 | businesswire.com Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVS Media Mentions By Week BVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVS News Sentiment▼-0.330.50▲Average Manufacturing News Sentiment BVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVS Articles This Week▼02▲BVS Articles Average Week Get the Latest News and Ratings for BVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bioventus and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MMED News WRBY News SLNO News TMDX News LMAT News AXGN News ESTA News NVCR News EYE News AORT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BVS) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
